Our Grants

CIRM provides funding across five key areas: Infrastructure, Education, Discovery Research, Translational Research, and Clinical Research. By supporting projects at every stage of development, from initial discovery to clinical trials, CIRM drives progress in regenerative medicine and accelerates innovative therapies to patients.

See our complete portfolio of awards below.

View Funded Institutions
View Funded Investigators
Find Clinical Trials

All CIRM Grants

Search Filters »

Institution Researcher name Grant Type Grant Title Award Value
University of California, Los Angeles Dr. Ali Nsair MD Basic Biology III Characterization and Engineering of the Cardiac Stem Cell Niche $1,127,741
Stanford University Dr. Michael F Clarke Basic Biology III USP16 controls stem cell number: implications for Down Syndrome $1,263,826
University of California, San Francisco John Murnane Basic Biology III Genomic instability during culturing of human embryonic stem cells $1,070,919
University of California, San Diego Dr. Binhai Zheng Dr. Basic Biology III Generation and characterization of corticospinal neurons from human embryonic stem cells $1,355,063
Stanford University Dr. Joanna Wysocka PhD Basic Biology III Enhancer-mediated gene regulation during early human embryonic development $1,420,618
University of California, San Diego Dr. Farah Sheikh Dr. Basic Biology III Molecular Mechanisms Underlying Human Cardiac Cell Junction Maturation and Disease Using Human iPSC $1,341,955
University of California, Los Angeles William Lowry Basic Biology III Molecular determinants of accurate differentiation from human pluripotent stem cells $677,115
University of California, Los Angeles Dr. Shuo Lin Dr. Basic Biology III Etsrp/ER71 mediated stem cell differentiation into vascular lineage $1,378,781
Parkinson’s Institute R. Jeremy Nichols Basic Biology III Understanding the role of LRRK2 in iPSC cell models of Parkinson’s Disease $1,482,822
Scripps Research Institute Kristin Baldwin Basic Biology III Identifying sources of mutation in human induced pluripotent stem cells by whole genome sequencing $1,705,500
University of California, Berkeley Dr. Michael P. Rapé Dr. Basic Biology III Ubiquitin-dependent control of hESC self-renewal and expansion $1,224,805
University of California, Los Angeles UCLA Gay Miriam Crooks Basic Biology III Forming the Hematopoietic Niche from Human Pluripotent Stem Cells $1,252,857
University of California, San Diego Dr. Charles C. King Dr. Basic Biology III Biological relevance of microRNAs in hESC differentiation to endocrine pancreas $1,313,649
University of California, Berkeley Dr. Song Li Basic Biology III Induced Pluripotent Stem Cells for Tissue Regeneration $1,209,148
University of California, San Diego Karl H. Willert Tools and Technologies II Homologous recombination in human pluripotent stem cells using adeno-associated virus. $1,659,043
Stanford University Dr. Marius Wernig MD, PhD Tools and Technologies II Cellular tools to study brain diseases affecting synaptic transmission $1,664,382
Stanford University Professor Irving L Weissman MD Tools and Technologies II Antibody tools to deplete or isolate teratogenic, cardiac, and blood stem cells from hESCs $1,463,814
TriFoil Imaging, Inc. Dr. Joann Zhang Tools and Technologies II Tri-resolution Visualization System for Stem Cells and Tissue Regeneration Monitoring $1,456,989
Cedars-Sinai Medical Center Professor Clive Niels Svendsen Tools and Technologies II Use of iPS cells (iPSCs) to develop novels tools for the treatment of spinal muscular atrophy. $1,933,022
University of California, Berkeley David Schaffer Tools and Technologies II Engineering Defined and Scaleable Systems for Dopaminergic Neuron Differentiation of hPSCs $1,340,816
Stanford University Dr. Brian K. Rutt Tools and Technologies II Development of Single Cell MRI Technology using Genetically-Encoded Iron-Based Reporters $1,833,348
Parkinson’s Institute Dr. Birgitt Schuele Tools and Technologies II Editing of Parkinson’s disease mutation in patient-derived iPSCs by zinc-finger nucleases $1,327,983
University of California, San Francisco Dr. Daniel A. Lim MD, PHD Tools and Technologies II Development and preclinical testing of new devices for cell transplantation to the brain. $1,795,891
GMR Epigenetics Dr. Jifan Hu Tools and Technologies II Robust generation of induced pluripotent stem cells by a potent set of engineered factors $1,356,052
Cedars-Sinai Medical Center Professor Clive Niels Svendsen Disease Team Therapy Planning I Stem Cells Secreting GDNF for the Treatment of ALS $63,487
University of California, San Diego Armin Blesch Progression Award – Discovery Stage Research Projects Simplification of Excipient Solution for Implanting Candidate Human H9-scNSC Cell Line for Spinal Cord Injury $180,000
Stanford University Dr. Helen M Blau Progression Award – Discovery Stage Research Projects Stimulating endogenous muscle stem cells to counter muscle wasting $237,060
University of California, Irvine Dr. Brian J. Cummings Progression Award – Discovery Stage Research Projects Human neural stem cell (hNSC) derived exosomes vs CSC14 hNSCs for the treatment of traumatic brain injury (TBI) $202,667
University of California, Berkeley Kevin E. Healy Progression Award – Discovery Stage Research Projects Safety “Clinical Trial” of the Cardiac Liability of COVID19 Polytherapy $224,500
University of California, Los Angeles Dr. Caroline Y. Kuo Progression Award – Discovery Stage Research Projects Evaluation of Gene Therapy Approaches for Autosomal Recessive Hyper IgE Syndrome Due to Mutations in DOCK8 $234,000
Neurona Therapeutics Dr. Cory R Nicholas Progression Award – Discovery Stage Research Projects Global gene expression profiling of single inhibitory neurons derived from human stem cells $202,500
Stanford University Professor Hiromitsu Nakauchi Progression Award – Discovery Stage Research Projects Using metabolic pausing for maintaining stable and high-quality pluripotent stem cells $208,422
Aspen Neuroscience Dr. Andres Bratt-Leal Progression Award – Discovery Stage Research Projects Autologous therapy for Parkinson’s disease: single cell RNAseq for in depth characterization of transplanted cells $177,579
1 … 22 23 24 25 26 27 28 29 30 31 32